| Literature DB >> 27004463 |
Vincenzo G Fiore1,2, Francesco Rigoli1, Max-Philipp Stenner1,3, Tino Zaehle3, Frank Hirth4, Hans-Jochen Heinze3,5, Raymond J Dolan1,6.
Abstract
Action selection in the basal ganglia is often described within the framework of a standard model, associating low dopaminergic drive with motor suppression. Whilst powerful, this model does not explain several clinical and experimental data, including varying therapeutic efficacy across movement disorders. We tested the predictions of this model in patients with Parkinson's disease, on and off subthalamic deep brain stimulation (DBS), focussing on adaptive sensory-motor responses to a changing environment and maintenance of an action until it is no longer suitable. Surprisingly, we observed prolonged perseverance under on-stimulation, and high inter-individual variability in terms of the motor selections performed when comparing the two conditions. To account for these data, we revised the standard model exploring its space of parameters and associated motor functions and found that, depending on effective connectivity between external and internal parts of the globus pallidus and saliency of the sensory input, a low dopaminergic drive can result in increased, dysfunctional, motor switching, besides motor suppression. This new framework provides insight into the biophysical mechanisms underlying DBS, allowing a description in terms of alteration of the signal-to-baseline ratio in the indirect pathway, which better account of known electrophysiological data in comparison with the standard model.Entities:
Mesh:
Substances:
Year: 2016 PMID: 27004463 PMCID: PMC4804216 DOI: 10.1038/srep23327
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.379
Figure 1Direct, hyperdirect and indirect pathways of the basal ganglia.
(a) Anatomical (left) and (b) schematic (right) representations of a sensorimotor striato-thalamo-cortical circuit highlighting the presence of the major pathways and the way they contribute to the gain in the neural circuit. Thal = thalamus; GPi = globus pallidus pars interna; GPe = globus pallidus pars externa; STN = subthalamic nucleus; SNr = Subtantia Nigra pars Reticulata. Str (D1) and (D2) represent the areas of the striatum characterised by high concentration of either D1 or D2 receptors.
Figure 2Visual Discrimination Task.
Task used for the two behavioural studies. Four black and white images in a cross shape form a series of static luminance patterns that change with a variable interval. The participants are tasked to use the keyboard to choose the image they consider the brightest and then to keep pressing the chosen key until a new luminance pattern is presented and a new selection is necessary. The grey line represents the feedback provided to the participants and, in this illustration of an ideal behaviour, always represents the selection of the correct cue.
Figure 3Behavioural indices recorded in Experiment 1.
(a) maintenance: time spent keeping a key pressed, which shows the treatment significantly increases the ability of the patient to maintain a selection (t(20) = 2.62, p = 0.016); (b) perseverance: time required to disengage from a selection after each change of luminance pattern on the screen, which shows the treatment significantly increases the chances the patient will persevere in any selection (t(20) = 2.14, p = 0.045); (c) number of changes of selection or switches, per luminance pattern, which does not show a significant effect of treatment (t(20) = −1.4648, p = 0.16). Histograms represent mean measures and standard deviation, per trial, under on- and off- subthalamic stimulation. Triangular markers represent mean values per participant, under each condition. The distribution in quartiles of within subject differences, per measure, is represented in the boxplots. Statistical significance (T test comparisons) expressed as follows: **for p ≤ 0.01; *for 0.05 > p ≥ 0.01; (ns) for not significant.
Parkinson’s disease patients and their treatment.
| Patient # | Age [years] | Gender | Disease duration [years] | assessment post surgery [months] | UPDRS III Score On/Off | LED [mg/d] | DBS contacts | DBS voltage [V], frequency [Hz], pulse with [μs] |
|---|---|---|---|---|---|---|---|---|
| 1 | 58 | m | 32 | 33 | 16/ | 100 | 0− 2+/8− 10+ | 2,5 V, 130 Hz, 60 μs/2, 7 V, 130 Hz, 60 μs |
| 2 | 64 | m | 10 | 57 | 16/32 | 705 | 3− 1+/7− 5+ | 5, 0 V, 130 Hz, 60 μs/4, 5V, 130 Hz, 60 μs |
| 3 | 67 | m | 17 | 69 | 8/ | 780 | 2− G+/4− 6+ | 2, 0 V, 130 Hz, 60 μs/3, 5 V, 130 Hz, 60 μs |
| 4 | 65 | m | 14 | 13 | 17/21 | 0 | 2− G+/9− G+ | 4, 5 V, 130 Hz, 60 μs/3, 7 V, 130 Hz, 60 μs |
| 5 | 67 | f | 34 | 120 | C+6−/C+3− | 2, 3 V, 180 Hz, 60 μs/2, 3 V, 180 Hz, 60 μs | ||
| 6 | 63 | f | 23 | 36 | 12/33 | 920 | 9− G+/2− G+ | 2, 5 V, 130 Hz, 60 μs/3, 5 V, 130 Hz, 60 μs |
| 7 | 56 | m | 9 | 9 | 2/21 | 0 | 2− G+/10− G+ | 2, 0 V, 130 Hz, 60 μs/2, 5V, 130 Hz, 60 μs |
| 8 | 53 | m | 6 | 52 | 1/29 | 326 | 1− 2+/9− 11+ | 2, 0 V, 130 Hz, 60 μs/4, 0 V, 130 Hz, 60 μs |
| 9 | 59 | m | 11 | 28 | 15/27 | 0 | 2− G+/11− G+ | 1, 1 V, 60 Hz, 60 μs/3, 6 V, 60 Hz, 60 μs |
| 10 | 65 | f | 10 | 57 | 5/27 | 0 | 1− G+/6− G+ | 2, 0 V, 130 Hz, 60 μs/2, 5V, 130 Hz, 60 μs |
| 11 | 40 | m | 5 | 12 | 22/26 | 0 | 3− G+/11− G+ | 2, 0 V, 130 Hz, 90 μs/2, 0 V, 130 Hz, 90 μs |
| 12 | 58 | m | 12 | 50 | 8/38 | 402 | 1− G+/9− G+ | 2, 1 V, 160 Hz, 60 μs/2, 1 V, 160 Hz, 60 μs |
| 13 | 68 | m | 12 | 12 | /31 | 255 | 1− G+/9−G+ | 1, 4 V, 180 Hz, 60 μs/2, 8 V, 180 Hz, 60 μs; |
| 14 | 54 | m | 14 | 49 | 9/28 | 310 | 3− G+/11− 10+ | 1, 6 V, 180 Hz, 60 μs/4, 5 V, 180 Hz, 60 μs |
| 15 | 55 | m | 9 | 35 | 28/28 | 1400 | C+3−/C+11− | 2, 8 V, 130 Hz, 90 μs/2, 0 V, 130Hz, 90 μs |
| 16 | 61 | m | 12 | 56 | 6/15 | 150 | G+3−/G+11− | 3, 0 V, 125 Hz, 60 μs/2, 6 V, 125 Hz, 60 μs |
| 17 | 53 | f | 9 | 8 | /26 | 0 | 0− G+/8− G+ | 2, 0 V, 130 Hz, 60 μs/2, 1 V, 130 Hz, 60 μs |
| 18 | 67 | m | 8 | 55 | 16/24 | 1010 | 2− G+/10− G+ | 0, 8 V, 130 Hz, 60 μs/2, 4 V, 130 Hz, 60 μs |
| 19 | 70 | m | ? | 74 | 15/ | 500 | 3+2−/7+6− | 4, 0 V, 130 Hz, 130 μs/4, 0 V, 130 Hz, 130 μs |
| 20 | 62 | f | 20 | 18 | /40 | 530 | 2− G+/10− G+ | 3, 5 V, 180 Hz, 60 μs/3, 5 V, 180Hz, 60 μs |
| 21 | 70 | f | 17 | 87 | 1− G+/4− G+ | 3, 6 V, 180 Hz, 60 μs/4, 2 V, 180 Hz, 60 μs |
Figure 4Simulated selections.
An arbitrary visual input (a) representing four images characterised by different brightness, that change luminance pattern every 5 seconds. The first control simulation (b) shows the ideal behaviour: the artificial agent chooses in each interval the position associated to the brightest image (in this example, the correct sequence is: up, left, down, right). The condition of control is characterised by a set of parameters allowing quick initiation of selections as a response to the sensory input and continuous maintenance for the duration of the luminance pattern. The same parameters as the control, but for the reduced DA drive have been used to show the agent exhibits distinct behaviours, depending on the strength of the sensory stimulus. (c) Weak stimuli result in motor suppression; (e) conversely, strong sensory stimuli are associated with selections continuously changed with ambitendency among the strongest competitors. In both cases, the agent shows short perseverance after each change of luminance pattern. Finally, the simulated selections associated with Parkinson’s disease treated with subthalamic DBS (d) show the agent is again capable of performing correct choices and maintain a chosen selection. On the downside, the perseverance increases significantly as the agent shows problems in disengaging after a change in luminance pattern.
Figure 5Simulated oscillatory neural activity in the BG under the condition of healthy control, low DA drive (DBS off) and high DA drive (DBS on).
Simulated activity recorded in the Globus Pallidus (pars interna: GPi, and pars externa: GPe) and the subthalamic nucleus (STN) in the three conditions of control and low DA drive, on and off-stimulation. The graphs report 10 seconds of activity (range between 15 and 25) resulting in the action selection reported in the case study represented in Fig. 4. The colorcode is used to represent the activity of neural units belonging to the same channel, within different neural regions. The selected time interval highlights the presence of both slow (frequency of 0.5–2 Hz) and ultra-slow oscillatory patterns (frequency <0.5 Hz). The first type is mainly induced by the switching function realised by the short indirect pathway, whereas the second results from the maintenance function regulated by the direct pathway.
Figure 6Action selections under on- and off- simulated subthalamic DBS.
Indices of simulated behaviour: (a) maintenance, (b) perseverance and (c) switches of 12 randomly selected seeds, tested under four different conditions (on and off simulated treatment times high and low valued inputs). Histograms represent mean measures and standard deviation, per trial, under simulated on- and off- subthalamic stimulation, across reward conditions. Markers represent mean values per participant. Within each histogram, the markers have been grouped so that the squares represent measures recorded under the condition of low values and circles represent measures recorded under the condition of high values. Boxplots represent the distribution of within seed differences, with red markers used to highlight the presence of any outlier. Each measure reports the distribution of difference across value condition (left), and under either high (centre) or low (right) value separately. Both for the index of maintenance (a) and for the index of perseverance (b), the distribution of within seed differences shows these measures vary as a function of the treatment condition but they are not significantly affected by the value condition (F = 23.281, p = 0.001, and F = 39.881, p < 0.001, respectively). Conversely, in the measure of switches (c) we observed an interaction effect of the two variables of value and simulated treatment (F = 17.696, p = 0.001). When comparing on and off simulated DBS the number of switches decreases (standard motor suppression) under low values and it increases (excessive switching) under high value condition ((t(11) = 5.61, p < 0.001 and t(11) = −3.12, p = 0.009, respectively). If considered across value condition, the behaviour does not vary significantly as a function of the simulated treatment alone, which might explain the absence of effect found in the same measure for the first experiment, where no reward manipulation was included. Statistical significance (two-way repeated-measures ANOVA) expressed as follows: ***for p ≤ 0.001. Note we do not establish a quantitative comparison between the simulated selections and the reported behaviour of the patients as we prefer to highlight the direction of measure comparison. This choice is reflected in the simulation by the presence of slightly different timing and number of time intervals for the input changes.
Figure 7Behavioural indices recorded in Experiment 2.
(a) maintenance, (b) perseverance and (c) switches, in 17 healthy participants under three conditions of pharmacological manipulation. Histograms represent mean values and standard deviation under placebo, DA antagonist (risperidone), and DA precursor (L-Dopa). Markers represent mean values per participant, grouped so to represent measures recorded under the condition of either low or high values (squares and circles, respectively). Boxplots represent the distribution in quartiles of within subject differences between measures recorded under placebo and DA antagonist: the two conditions have been selected to establish a comparison with experiment 1. Each measure reports the distribution of differences across value condition (left), and under either high (centre) or low (right) value separately. Two-way repeated measures 3 × 2 ANOVA indicates the presence of a trend in the interaction between pharmacological and reward conditions for the measure of switches (F = 2.501, p = 0.098). Follow-up analysis reveals a main effect of the pharmacological manipulation (F = 5.296, p = 0.035), irrespective of the associated reward, when comparing the measure of perseverance recorded under placebo and DA antagonist condition (b, right). Finally, two-way repeated measures 2 × 2 ANOVA confirms the presence of an interaction effect for the index of switches when comparing behaviour under DA antagonist with either placebo (c) or DA precursor (F = 3.121, p = 0.096 and F = 6.492, p = 0.021). In particular, the distribution of within subject differences (Placebo -DA antagonist, c, right), recorded under high reward condition, shows the predicted increase in terms of number of switches per luminance pattern under the low DA drive pharmacological manipulation. Statistical significance in the figure, relative to the preliminary 3 × 2 ANOVA is expressed as follows: T for 0.10 > p > 0.05; (ns) for not significant.
Figure 8Diagram of motor functions expressed by the standard and the enriched model.
Four motor modalities are here represented as ideally separate sets for illustrative purposes. The standard framework mainly includes the motor modalities associated with vigour or motivation (grey boxes). These motor functions can be spatially represented on a single axis, as a function of striatal DA drive. Conversely, the proposed enriched model includes all four modalities (grey and white boxes), and requires a spatial representation on two axes, as a function of both striatal DA drive and strength of information propagated via the short indirect pathway (i.e. via direct inhibitions from GPe to GPi). The diagram illustrates the more comprehensive representation offered by the enriched model does not exclude any of the modalities presented in the standard model, and at the same time it allows a more precise association of each modality with specific neural causes.